BELLUS Health Inc. announced that biotech entrepreneur Dr. Clarissa Desjardins is joining its Board of Directors. Dr. Desjardins is the Chief Executive Officer and Founder of Clementia Pharmaceuticals Inc., a clinical stage biopharmaceutical company. In addition to founding Clementia in 2011, she established and helped build two other successful biotech companies: Advanced Bioconcept and Caprion Pharmaceuticals. Concurrent with the appointment of Dr. Desjardins, BELLUS Health also announced that Dr. Martin Tolar will be stepping down from the Company's Board of Directors.